EDITORIAL article

Front. Immunol., 20 November 2018

Sec. Alloimmunity and Transplantation

Volume 9 - 2018 | https://doi.org/10.3389/fimmu.2018.02713

Editorial: Non-coding RNAs and Graft versus Host Disease

  • 1. Department of Internal Medicine, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, United States

  • 2. Department of Hematology, Oncology and Stem Cell Transplantation, Freiburg University Medical Center, Albert Ludwigs University of Freiburg, Freiburg, Germany

Acute graft-vs.-host disease (GVHD) causes activation of multiple pro-inflammatory pathways in a diverse array of immune cell subsets that are often regulated by micro RNAs (miRs). MiRs are small non-coding RNAs that post-transcriptionally regulate gene expression and thereby impact inflammatory events at multiple levels including the release cytokines, chemokines, signaling by their receptors, cell-cycling, migration, and filament stabilization. Multiple inflammation-related miR-target genes are described, and while some miRs target anti-inflammatory genes other promote inflammation by targeting immunosuppressive genes. Additionally, the same miR can have different effects by preferentially targeting certain genes depending on the cell type and their context, in which the miR is analyzed. Through these diverse effects in various critical immune cell subsets miRs play critical functional role in GVHD and graft-vs.-leukemia effects (GVL). Thus, miRs are potentially attractive targets for the modification of allogeneic immune responses using miR mimics and inhibitors. Additionally, miR-levels in different body fluids could help to guide clinical decision making and function as biomarkers to predict or diagnose GVHD. This Research Topic, authored by experts in the field, describes the pleomorphic function of different miRs as potent regulators of multiple pro- or anti-inflammatory target genes, in various immune cell subsets that affect alloimmunity and GVHD. A better understanding of the miR-biology may help to mitigate GVHD and augment GVL effects and improve the outcomes after allogeneic hematopoietic transplantation.

Statements

Author contributions

All authors listed have made a substantial, direct and intellectual contribution to the work, and approved it for publication.

Funding

This work was supported by ERC (grant number 681012) to RZ (GVHDCure).

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Summary

Keywords

GvHD, micro RNA, Inflammation, non-coding RNAs, T cell

Citation

Reddy P and Zeiser R (2018) Editorial: Non-coding RNAs and Graft versus Host Disease. Front. Immunol. 9:2713. doi: 10.3389/fimmu.2018.02713

Received

16 October 2018

Accepted

05 November 2018

Published

20 November 2018

Volume

9 - 2018

Edited and reviewed by

Antoine Toubert, Paris Diderot University, France

Updates

Copyright

*Correspondence: Robert Zeiser

This article was submitted to Alloimmunity and Transplantation, a section of the journal Frontiers in Immunology

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics